WISP3 Gene Arthropathy progressive pseudorheumatoid of childhood Genetic Test
Test Details
The WISP3 gene is associated with a rare genetic disorder called progressive pseudorheumatoid arthropathy of childhood (PPAC). PPAC is characterized by progressive joint stiffness, pain, and swelling, which can lead to joint deformities and limited mobility.
NGS (Next-Generation Sequencing) genetic testing can be used to identify mutations or variations in the WISP3 gene that are responsible for PPAC. NGS is a high-throughput sequencing method that allows for the simultaneous analysis of multiple genes or even the entire exome (the protein-coding region of the genome).
NGS genetic testing for WISP3 gene mutations can help confirm a diagnosis of PPAC and guide treatment decisions. It can also be used for carrier testing in families with a history of PPAC, as it is an autosomal recessive disorder.
Test Name
WISP3 Gene Arthropathy progressive pseudorheumatoid of childhood Genetic Test
Components
Price: 4400.0 AED
Sample Condition
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery
3 to 4 Weeks
Method
NGS Technology
Test type
Osteology Dermatology Immunology Disorders
Doctor
Dermatologist
Test Department
Genetics
Pre Test Information
Clinical History of Patient who is going for WISP3 Gene Arthropathy, progressive pseudorheumatoid, of childhood NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with WISP3 Gene Arthropathy, progressive pseudorheumatoid, of childhood NGS Genetic DNA Test gene WISP3
Test Name | WISP3 Gene Arthropathy progressive pseudorheumatoid of childhood Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Osteology Dermatology Immunology Disorders |
Doctor | Dermatologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for WISP3 Gene Arthropathy, progressive pseudorheumatoid, of childhood NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with WISP3 Gene Arthropathy, progressive pseudorheumatoid, of childhood NGS Genetic DNA Test gene WISP3 |
Test Details |
The WISP3 gene is associated with a rare genetic disorder called progressive pseudorheumatoid arthropathy of childhood (PPAC). PPAC is characterized by progressive joint stiffness, pain, and swelling, which can lead to joint deformities and limited mobility. NGS (Next-Generation Sequencing) genetic testing can be used to identify mutations or variations in the WISP3 gene that are responsible for PPAC. NGS is a high-throughput sequencing method that allows for the simultaneous analysis of multiple genes or even the entire exome (the protein-coding region of the genome). NGS genetic testing for WISP3 gene mutations can help confirm a diagnosis of PPAC and guide treatment decisions. It can also be used for carrier testing in families with a history of PPAC, as it is an autosomal recessive disorder. |